This therapeutic class currently includes five agents: canagliflozin, dapagliflozin, empagliflozin, ertugliflozin, and sotagliflozin
WeightWatchers is the global leader in science-backed weight management, providing an accessible, holistic model of care through our #1 U.S
More research is needed to fully understand the effects of BPC 157 in the long term
A person with a history of MTC, a patient with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a patient with a prior serious allergic reaction to semaglutide GLP-1s ingredients, or someone who has had pancreatitis should not take Mounjaro (tirzepatide)
Some prescribers use both together for enhanced appetite suppression, particularly during the early weeks when semaglutide has not yet reached full effect
NICE guidance provides clear recommendations for GLP-1 use, which focus exclusively on glycaemic control in type 2 diabetes (NG28) and weight management in obesity (TA875 for semaglutide, TA664 for liraglutide)